Skip to main content
CAMBIUM BIO LIMITED logo

CAMBIUM BIO LIMITED — Investor Relations & Filings

Ticker · CMB ISIN · AU0000327769 ASX Professional, scientific and technical activities
Open in API
Filings indexed 504 across all filing types
Latest filing 2020-09-10 Major Shareholding Noti…
Country AU Australia
Listing ASX CMB

About CAMBIUM BIO LIMITED

https://www.cambium.bio

Cambium Bio Limited is a clinical-stage regenerative medicine company focused on developing innovative cellular therapies to treat unmet medical needs in ophthalmology and inflammatory diseases. The company's primary focus is on its lead candidate, EluRegen, a first-in-class topical biologic designed for the treatment of corneal epithelial defects and dry eye disease. Utilizing its proprietary technology platforms, the company aims to harness the regenerative potential of biologics to provide effective treatments for chronic conditions. In addition to its ophthalmic pipeline, the company maintains assets in the field of mesenchymal stem cell therapies, including Progenza, which targets osteoarthritis and neuropathic pain. The company emphasizes a data-driven approach to clinical development, seeking to improve patient outcomes through advanced tissue engineering and cell-based solutions.

Recent filings

Filing Released Lang Actions
Notice of initial substantial holder - AGC Inc. 2 pages 123.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder under the Corporations Act 2001. It details the substantial shareholding of AGC Inc. in Regeneus Ltd, including voting power, relevant interests, registered holders, consideration paid, and addresses. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, management report, or any other type of report but a regulatory notification about shareholding thresholds being crossed.
2020-09-10 English
Cleansing Notice 1 page 97.6KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth), announcing the issuance of ordinary shares without disclosure under Part 6D.2 of the Corporations Act. It is a formal regulatory announcement related to share issuance and compliance with disclosure obligations. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an announcement about a capital transaction and compliance notice, fitting the category of Capital/Financing Update (CAP). The document length is short and focused on a specific capital issuance event, confirming it is not a full report or other filing type.
2020-09-09 English
Appendix 2A 15 pages 253.9KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance and quotation of securities, referencing previous announcements and transactions. This type of document is a formal announcement related to capital raising and securities issuance, specifically an application for quotation of new securities. It is not a financial report, earnings release, or management discussion. It fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2020-09-09 English
Issue of AGC shares complete 1 page 120.0KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 10 September 2020 regarding the completion of an issue of shares to a strategic investor, AGC Inc. It mentions the issuance of 22,459,393 shares and references a previous announcement about terminating a joint venture agreement. The content focuses on a capital transaction involving share issuance and strategic investment. The document length is short (1650 characters) and it is clearly an announcement of a financing event rather than a detailed financial report or other types of filings. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-09-09 English
Notice of initial substantial holder - Kirman 2 Pty Ltd 3 pages 164.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001. It details the acquisition of a substantial shareholding in Regeneus Ltd by Kirman 2 Pty Ltd and Brian Michael Sherman, including voting power, relevant interests, and consideration paid. This type of filing is a notification of a major shareholding change, specifically the crossing of a substantial ownership threshold. It is not a financial report, management announcement, or other types of filings such as earnings releases or governance information. Therefore, the correct classification is Major Shareholding Notification (MRQ). The document length and content confirm it is a substantive notification rather than a brief announcement or certification.
2020-09-07 English
CEO bonus payment 1 page 122.1KB
Remuneration Information Classification · 95% confidence The document is an ASX announcement dated 3 September 2020 regarding a one-off cash bonus payment to the CEO of Regeneus Ltd following a licensing and collaboration agreement with Kyocera Corporation. The content focuses on the bonus payment related to a commercial agreement and does not contain financial statements, quarterly or annual results, or detailed financial data. It is not a report, transcript, or regulatory filing about financial performance or governance changes. The document is an announcement about a management remuneration event (CEO bonus payment) authorized by the Board. Therefore, the most appropriate classification is Remuneration Information (DEF 14A). The document length is short and focused on remuneration, not a full report or regulatory filing.
2020-09-02 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.